Back to Results
First PageMeta Content
Thiazides / Diuretics / Tetrazoles / Lactams / Irbesartan / Trichlormethiazide / Angiotensin II receptor antagonist / Antihypertensive drug / Hypertension / Chemistry / Organic chemistry / Organochlorides


Document Date: 2014-11-03 11:26:24

Open Document

File Size: 74,73 KB

Share Result on Facebook

City

Osaka / /

Company

Merck & Co. Inc. / Shionogi & Co. Ltd. / Sanofi / Schering-Plough Corp. / Corporate Communications Department Shionogi & Co. Ltd. / /

Country

France / Japan / United States / /

Currency

JPY / /

Event

FDA Phase / /

/

IndustryTerm

treatment for hypertension / combination product / Treatment of Hypertension / therapy for hypertension / foreign healthcare reforms / with respect to product / /

MedicalCondition

hypertension / premenstrual syndrome / uncontrolled hypertension / essential hypertension / severe hypertension / /

Person

Isao Teshirogi / /

/

Position

President & CEO / /

Product

HD tablet / Combination Tablets / irbesartan / trichlormethiazide / Tablets LD / IRTRAⓇCombination Tablets / IRTRA® Combination Tablets LD / /

SocialTag